Focus Area: Bioinspired Therapeutics & Diagnostics
253 Results for 'Bioinspired Therapeutics & Diagnostics'
- Technologies (20)
- Team (0)
- News (182)
- Events (0)
- Multimedia (51)
- Publications (0)
- Jobs (0)
Technologies 20
-
Broad-Spectrum RNA Therapeutic for COVID-19 and Influenza
The COVID-19 pandemic has killed more than two million people worldwide and death tolls continue to mount due to the lack of an effective prevention, cure, or widespread vaccine for the disease. Influenza viruses have been even more deadly in the past, and still cause hundreds of thousands of deaths every year. Seasonal flu vaccines... -
Cellular “Backpacks” to Slow Tumor Growth
Macrophages are the body’s multipurpose defense agents, patrolling for pathogens and engulfing cellular debris, foreign substances, microbes, and even cancer cells. But cancerous tumors have evolved an insidious defense mechanism: they can switch arriving macrophages from an anti-cancer state to a pro-cancer state, in which they help promote the tumor’s growth. As a result, attempts... -
Using Systems Biology to Find and Test New Drugs Faster
The pharmaceutical industry is infamous for big numbers: it takes 10-15 years and can cost over $2 billion to bring a new drug from the lab to the market. Up to 6 of those years and $1 billion are spent in laborious preclinical trials to identify and validate new potential drug compounds, and much of... -
eRapid: Multiplexed Electrochemical Sensors for Fast, Accurate, Portable Diagnostics
Handheld electrochemical sensors have revolutionized at-home medical testing for diabetics, but they have not yet been successfully applied to diagnosing other conditions. These sensors are based on the activity of an enzyme, and there are only a limited number of enzymes that can be used to detect biomarkers of human disease. An alternative, much more... -
Brain Targeting Program: Shuttles for Brain Delivery of Therapeutics and Diagnostics
In its Brain Targeting Program, a Wyss team led by Founding Director Donald Ingber, M.D., Ph.D. and Staff Program Lead James Gorman, M.D., Ph.D. is developing improved approaches to target drugs and diagnostics to the brain. Leveraging the human blood-brain barrier (BBB) Chip technology developed by Ingber’s team, combined with advanced antibody R&D capabilities, the... -
Injectable Alginate Hydrogels for Medical Applications
One of the biggest challenges in medicine is getting a drug to the right part of the body at the right time. Even when the target site in the body is known, like a pain-causing injury or a cancerous tumor, most drugs are given as oral pills or intravenous infusions, which limits their effectiveness. In...
News 182
Multimedia 51
-
Video/AnimationNature Can Help Us Prepare for the Next PandemicResiliency, redundancy, adaptability: COVID-19 has shown humanity that we need more of the qualities that are built into nature. See how a cat’s tongue inspired Wyss Lead Staff Engineer Richard Novak to create a novel nasal swab design to aid in COVID-19 diagnostics. -
Video/AnimationThe electrical blueprints that orchestrate life | Michael Levin TED TalkDNA isn’t the only builder in the biological world — there’s also a mysterious bioelectric layer directing cells to work together to grow organs, systems and bodies, says biologist and Wyss Associate Faculty member Michael Levin. Sharing unforgettable and groundbreaking footage of two-headed worms, he introduces us to xenobots — the world’s first living robots,... -
Audio/PodcastResearching Biosensors with Dr. Pawan JollyPoint of Care Medical Devices are the future! Pawan Jolly, Ph.D., Senior Staff Scientist at The Wyss Institute for Biologically Inspired Engineering at Harvard University talks with Jonah and Aryan of the Beyond the Books podcast about his research in the biosensor and medical device arena. They ask him about his latest COVID-19 focused project,... -
Video/AnimationUsing deep learning to detect cancerous skin lesionsMelanoma is a very severe cancer that is often diagnosed too late to save patients’ lives, and most people do not regularly visit a dermatologist for skin exams. Early-stage identification of suspicious pigmented lesions (SPLs), ideally by primary care providers, could lead to improved melanoma prognosis. Researchers at the Wyss Institute and MIT have developed... -
Audio/PodcastMichael Levin on Growth, Form, Information, and the SelfOn Mindscape, Sean Carroll hosts conversations with some of the most interesting thinkers in the world. From neuroscientists and engineers to authors and television producers, Sean and his guests talk about the biggest ideas in science, philosophy, culture and much more. In this episode, he talks with Wyss Associate Faculty member Michael Levin about how... -
Video/AnimationAdvancing Science and Technology Innovation By Crossing the Art-Science-Design InterfaceWyss Founding Director Donald E. Ingber, M.D., Ph.D., presented on Advancing Science and Technology Innovation by Crossing the Art-Science-Design Interface at the KAUST Circular Carbon Initiative’s 2021 virtual Winter Enrichment Program. Ingber discussed his path from a serendipitous experience in an undergraduate art class that led to his discovery of how living cells are constructed...